Alessandro Antonelli

Prof. Antonelli is currently Full Professor of Internal Medicine in the Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, Director of the Immuno-Endocrine Section of Internal Medicine, and Director of a Laboratory of Primary Human Cells, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy. His areas of expertise are Autoimmune Thyroid Disorders, Thyroid Cancer, Systemic autoimmune disorders, HCV, Type 1 Diabetes, Cytokines and Chemokines.

Some of his main research activity outcomes are: a) He showed the appearance of thyroid cancer in children from Belarus after the Chernobyl accident; b) He first demonstrated the importance of the chemokines CXCL10, CXCL9, CXCL11 and CCL2 in the pathogenesis of Hashimoto’s thyroiditis, Graves’ disease and Graves’ ophthalmopathy, and in thyroid cancer; c) He first showed the efficacy of novel tyrosine-kinase inhibitors in primary cell cultures of dedifferentiated thyroid cancer; d) He studied the association of thyroid autoimmune disorders and systemic autoimmune diseases; e) He studied the Covid epidemiology in patients with systemic autoimmune diseases.

His researches have been published in more than 400 articles on International journals (Impact Factor >1600; H index 76).